SARS-CoV-2 spike E484K mutation reduces antibody neutralisation.

Jangra, Sonia, Chengjin Ye, Raveen Rathnasinghe, Daniel Stadlbauer, Personalized Virology Initiative study group, Florian Krammer, Viviana Simon, Luis Martinez-Sobrido, Adolfo García-Sastre, and Michael Schotsaert. 2021. “SARS-CoV-2 Spike E484K Mutation Reduces Antibody Neutralisation.”. The Lancet. Microbe 2 (7): e283-e284.
Last updated on 12/14/2023
PubMed